Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national
4
×
national blog main
national top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
cancer
clinical trial
crispr
crispr therapeutics
fda
loxo oncology
study
2025
ad-comm
affimed
akcea therapeutics
allogene therapeutics
amicus therapeutics
What
cancer
4
×
new
4
×
genetic
medicine
crispr
allogene
approved
bio
cas
cells
centers
cut
deeper
defect
depression
diversity
dna
drive
drug
edited
editing
event
fda
fears
fingerprint
flag
gene
going
guardian
guesswork
guide
helps
hot
human
immunotherapy
investors
ipo
juno
known
lab
Language
Current search:
cancer
×
national
×
new
×
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
@xconomy.com
5 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?
